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Summary 
Positive continuous outcomes with a point mass at zero are prevalent in biomedical research. To 
model the point mass at zero and to provide marginalized covariate effect estimates, 
marginalized two part models (MTP) have been developed for outcomes with lognormal and log 
skew normal distributions. In this paper, we propose MTP models for outcomes from a 
generalized gamma (GG) family of distributions. In the proposed MTP-GG model, the 
conditional mean from a two-part model with a three-parameter GG distribution is parameterized 
to provide regression coefficients that have marginal interpretation. MTP-gamma and MTP-
Weibull are developed as special cases of MTP-GG. We derive marginal covariate effect 
estimators from each model and through simulations assess their finite sample operating 
characteristics in terms of bias, standard errors, 95% coverage, and rate of convergence. We 
illustrate the models using data sets from The Medical Expenditure Survey (MEPS) and from a 
randomized trial of addictive disorders and we provide SAS code for implementation. The 
simulation results show that when the response distribution is unknown or mis-specified, which 
is usually the case in real data sets, the MTP-GG is preferable over other models.   
Key words: Generalized gamma; Marginalized two part model; Point mass at zero; Semi-
continuous data; Weibull. 
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1. Introduction 
Positive continuous outcomes with a point mass at zero are prevalent in biomedical research. 
Some common examples are antibody concentration [1], disability levels [2], medical costs [3], 
and individual alcohol consumption [4, 5]. Common practices for modeling these types of data 
are: 1) to assume a regular parametric response distribution, such as Gaussian, and fit a general 
linear model (GLM); 2) to exclude the zeroes and model the positive outcomes via GLM; 3) to 
log transform the outcome after adding a small constant to the zero values and fit a GLM; or 4) 
to fit a two-part (TP) model. However, a simple parametric distribution, such as Gaussian, for 
example, cannot accommodate the large number of zeroes nor the skewness of the data, and will 
therefore lead to biased inferences [6]. Similarly, a log transformation cannot normalize the data 
due to the spike at zero, and will often result in an asymmetric distribution [7]. Tobin, and later 
Heckman, acknowledged the bias from an ordinary least square regression when used for 
continuous data with an abundance of zeroes, and proposed solutions such as the Tobit model [8] 
and Heckman’s selection model [9]. These models assume that the dependent variable follows a 
censored normal distribution and all zeroes are artificial zeroes (i.e., values below a detection 
limit).  
Two-part models, on the other hand, assume that all zeroes are valid responses, which makes 
them  a better alternative for skewed data with a true point mass at zero [10] resulting in a more 
meaningful interpretation in applications where the zeroes are legitimate responses and not 
simply proxies for censored data. 
TP models were first suggested as a generalization of the delta distribution [11], and 
subsequently extended to a regression setting by including covariates in both parts of the model 
[7, 10, 12]. The usual terms used for the two parts are binary or occurrence and intensity or 
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continuous [13]. In general, the binary part uses a logit or a probit link to model the probability 
of being a positive value, whereas the continuous part models the non-zero values. Common 
distributions used for the non-zero values are lognormal, gamma [10, 14], generalized gamma 
(GG) [15], log skew normal (LSN) [16], and normal after the Box Cox transformation [5].  
One caveat with the TP model is that it leads to a conditional interpretation of the regression 
coefficients for the continuous part (i.e., conditional that the observed value is non-zero). In 
order to address this limitation, alternative methods have been proposed, such as the 
marginalized two part (MTP) model [13] which parameterizes the marginal mean among the 
zero and nonzero values directly in terms of regression coefficients. This leads to a 
straightforward interpretation of covariate effects on the marginal mean for the entire population 
comprising both the zero and nonzero responses.  
The MTP was originally developed for lognormal or log skew normal distributions. In this paper, 
we further extend the MTP model to the more flexible generalized gamma (GG) family of 
distributions. The GG was first mentioned by Amoroso in 1925 [17] but was later refined by 
Stacy, in 1962 [15] to include 3 parameters characterizing the location, scale and shape of the 
distribution. Because of this flexibility, the GG has the ability to represent many different types 
of distributions and can model a variety of data sets with different degrees of skewness and 
asymmetries. The GG family includes gamma, and Weibull as subfamilies, and the lognormal as 
a limiting distribution [18]. All of the aforementioned distributions can be used for the 
continuous part of TP and MTP model and more importantly, they can lead to substantially 
different inferences [10] [19].  Although distributions form the GG family have been used 
extensively in the continuous part of standard TP models, the MTP models have not yet been 
extended to accommodate this comprehensive family of distributions. Our aim, is to develop 
5 
 
MTP models for the GG family and determine which of these is most appropriate for a real data 
set or whether it leads to improved performance over existing MTP models when the underlying 
true distribution of the data is unknown.    
Our work is partly motivated by a randomized controlled trial that investigates the effect of 
Group Motivational Interviewing (GMI) compared to a treatment control condition (TCC) 
among 118 veterans. The investigator was interested to assess the effect of GMI on multiple 
substance use and treatment engagement outcomes [20, 21] such as peak standard ethanol 
content (peakSEC) or the SEC on the day that the participant drank the most and US dollars 
spent on alcohol (ALCmoney). The percentage of zeroes for these semi continuous outcomes 
was 40% and 48%, respectively. We also consider a second data example from MEPS, 
household component 2011 (HC-147), with an increased sample size (N=13,239) and outcomes 
(total health care expenditures, total emergency room expenditures) with different percentages of 
zeroes (16%, and 88%). The aim for this data example was to determine if there were significant 
differences between non-Hispanic Asians and non-Hispanic whites in terms of medical costs in 
2011, without conditioning on observing a non-zero cost.  
The remainder of this paper is organized as follow: In section 2 we develop MTP models for GG 
family of distributions (gamma, and Weibull distributions); in section 3 we compare the 
efficiency of different MTP models in a simulation study and present a model selection approach 
that uses both statistical information criteria and the estimated value of the shape and scale 
parameter from the MTP-GG model; in section 4 we apply our findings in two real data sets; and 
section 5 summarizes our findings and provides suggestions for future work. We also provide 
SAS code for implementation in the Appendix. 
2. Statistical Model and Inference  
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In the  notations used for this section, 
iy  represents the positive continuous outcome with a point 
mass at zero for observation i , f  is the probability density function (pdf) corresponding to a 
continuous distribution defined on a positive domain,
'
ix  is the covariate vector corresponding to 
subject i   used for the binary part, 
'
iz  is the covariate vector corresponding to observation i   
used for the continuous part of a TP or MTP model,     is the vector of model coefficients 
corresponding to the binary part of the TP or MTP model,    is the vector of conditional 
coefficients corresponding to the continuous part of a TP model and    is the vector of marginal 
coefficients corresponding to the continuous part of an MTP model. Below, we provide brief 
description of GG followed by descriptions of the TP and MTP models. 
2.1 The generalized gamma (GG) family of distributions 
Following the parameterization in Manning et al. [22], the pdf of a continuous random variable 
Y   following a GG distribution can be written as: 
 (y; , , ) exp{u exp(| | u)},
( )
f k k
y

   
  
 

  (1) 
where (.)  is the standard gamma function,         /u sign k log y µ   , for  shape parameter
k ,  location parameter 0   and scale parameter 0    and 
2
0k

  .  
The 
ths  moment of the GG distribution with the above parameterizations is given by: 
  
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It follows that the mean and variance of Y   are given by: 
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where: 
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Special cases: the gamma distribution is obtained when k  ; the Weibull distribution is 
obtained when 1k  ; the limiting distribution of the GG as 𝑘 → 0 is the lognormal distribution.  
2.2 Two part models (TP) 
The general form of the pdf of a TP model ( TPg ) [7] is given by: 
  
 
1 ,  0
g y
; ,  0
i i
TP
i
i
i if
if y
y if y


 
 

'
ix δ
  (6) 
where the probability of being non-zero, i  , can be modeled using a logit link: 
  ilogit  
'
iz α   (7) 
The location parameter i   is modeled in the second part of the TP model assuming a log link: 
 log( )i 
'
ix δ   (8) 
In general, the TP model will lead to a marginal interpretation (i.e. for the entire population 
including zero and non-zero outcomes) of model coefficients α  in the binary part and a 
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conditional interpretation of the coefficients    in the continuous part except for some special 
cases. For example, if the covariates used in the binary part are different than those used in the 
continuous part (no common covariate) or the zero part does not have any covariate, then the 
covariate regression coefficient from a TP have marginal interpretation. However, when there 
common covariates, the interpretation of the regression coefficient from the continuous part in a 
TP is conditional upon observing a non-zero outcome.  
The marginal mean and variance of iY  from a TP model can be derived as: 
     2 2V( ) E( | 0) E( | 0)E E | 0 ,  i i i ii ii i i i iY Y Y Y YY Y Y           (9) 
For example, when GG is assumed in the continuous part, then the marginal mean is, 
  
 
  
1
E( ) exp{ }
1 ex
, exp ,
p
i i i CY k C k      

'
i'
i-
x δ
z α
  (10) 
The variance of iY  corresponding to the TP model can be obtained using the variance formula in 
equations (9) and the sth moment for GG in equation (2).  
2.3 Marginalized two part models (MTP) 
The general form of the pdf for an MTP model ( MTPg ) [13] can be written as :  
  
 
1 ,  0
g y
; ,  0
i
i
i
MTP i
i if
if y
y if y


 
 

'
ix β
  (11) 
This gives a marginal mean of the form: 
  E exp( )i iY  
'
ix β   (12) 
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Solving for the location parameter of the GG distribution in the expression of (Y )iE  equation 
(10), we get the following parameterization: 
    μ log ,i i C k   
'
ix β   (13) 
We define C  from equation (5) for the subfamilies of the GG distribution as follows: for the 
MTP-gamma distribution 0C  , for the MTP-Weibull distribution   log[ (1 )]C      and for 
the MTP-lognormal distribution   2 / 2C   . A necessary condition for the distribution used 
in the continuous part of an MTP is to have a finite closed-form mean that can be parameterized 
as in equation (13). 
2.4 Statistical Estimation and Inference for MTP models 
The parameters of the MTP model are estimated using maximum likelihood. The general form of 
the likelihood function for the MTP-GG model is given by: 
  
1(y 0) 1(y 0)
( , , , | ) (1 ) (y ; , , )
i i
i i i i
i
L k y f k      
 
    (14) 
Where f is the pdf of GG distribution and the conditional mean i  is parameterized in terms of 
the marginal mean i  , as described in section 2.3. After substituting the i  by equation (13) and  
i  expressed in (7), we get the following likelihood form: 
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  (15) 
The likelihood function for the special cases gamma and Weibull can be derived in similar ways 
using the corresponding probability density functions. After taking the log of the likelihood 
function, the derivatives with respect to each parameter are equated to zero in order to get 
maximum likelihood estimates. The model based asymptotic standard errors are computed using 
Fisher information after substituting the maximum likelihood estimates for , ,k,    
corresponding to the MTP-GG model:   
 
1ˆ ˆˆ ˆˆ ˆˆ ˆvar( , ,k, ) {I ( , ,k, )}diag        (16) 
The beta coefficients from the MTP model represent population covariate, effects and exp( )j  is 
interpreted as the multiplicative effect on the unconditional marginal mean of Y  for one unit 
increase in jx  . 
The likelihood function can be maximized using SAS PROC NLMIXED. By default, the Dual 
Quasi Newton Rapson algorithm is used for optimization (more details in the appendix). 
Confidence intervals and p-values are obtained as part of the standard output in PROC 
NLMIXED. 
2.5 Model selection 
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Popular approaches to select the best model are the likelihood ratio test for nested models and the 
information criteria such as Akaike information criterion (AIC) [23] and Bayesian information 
criterion (BIC), for non-nested models. Both AIC and BIC are based on log likelihood and they 
both penalize for the number of parameters being estimated. The penalty is larger for BIC and 
therefore BIC usually prefers more parsimonious models. The model with the lowest AIC or BIC 
is selected as the best model. Another alternative for model selection is the Vuong test [24]. Due 
to its simplicity of implementation, the Vuong test is commonly used in the context of two part 
models to detect zero inflation. When the models are not strictly non-nested the use of the Vuong 
test is not appropriate [25]. Some models presented in this article are strictly non-nested, such as 
MTP-Weibull and MTP-gamma; we therefore used AIC for model selection. In addition to the 
AIC, we used the estimates of the shape and scale parameter of the MTP-GG as indicators for the 
most appropriate distribution. For example, if the shape parameter k  is estimated as being very 
low (close to zero), this would suggest that an MTP-lognormal might be appropriate. Similarly, 
if k  is close to one, then MTP-Weibull would be appropriate. If k  and the scale parameter   
have similar values, then MTP-gamma would be appropriate. If the parameter estimates do not 
match any of these scenarios and there are no large differences between AICs, then MTP-GG is 
considered the best alternative.  
3.  Simulation Study 
The purpose of the simulation study is to: (i) investigate the bias and consistency of the 
estimators in finite samples, (ii) compare asymptotic standard errors, (iii) verify if the confidence 
interval constructed for a parameter is able to achieve the 95% nominal level of coverage, (iv) 
verify if a hypothesis testing procedure will attain 0.05 size/level and if so, to determine what 
power is possible against different alternatives to the null hypotheses. Both percent relative mean 
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and median are used to estimate the average bias. We consider simulation scenarios for 3 
different sample sizes (N=100, N=500, N=1000), 4 distributions with different shape and scale 
parameters (lognormal, gamma, Weibull, GG) and 3 different covariate effects (
2 2 20, 0.5, 1.5       ). We compare the performance of MTP-lognormal, MTP-gamma, 
MTP-Weibull, MTP-GG and MTP log skew normal in terms of bias, relative efficiency, 95% 
coverage, type 1 error rate, attained power and convergence rates. A model was considered to 
have converged if the standard errors for each parameter that was estimated was non-zero and 
non-missing and if the convergence status outputted by SAS PROC NLMIXED indicated that 
the model has converged. 
3.1. Simulation design 
The data set was simulated from MTP models that assumed different distribution for the 
continuous part with different degrees of skewness: lognormal with 2 2   and 2 4   , gamma 
with shape parameter 0.2, 2, and 10, Weibull with shape parameter 0.25, 2 and 10 and GG with 
scale 0.3 and shape 5. The shapes of the distributions used for the continuous part of the MTP are 
presented in Web Figure1. The true model used for simulation is the MTP model as described in 
section 2.3 assuming two covariates in each part: 
 0 1 1 2 2logit( )i i ix x        (17) 
 0 1 1 2 2log( (Y ))i i iE x x       (18) 
Where 1x ~ N(10, 2)i  and i2 ~ Bernoulli(0.5)x . The parameter true values were set to 
' (4.9, 0.4, 1)     and ' (6.3, 0.5, 1.5)    . In order to evaluate type 1 error rate and power, we 
also simulated for 2 0   and 2 0.5   , respectively. The percentage of zeroes was about 40%, 
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similar to one of our motivating data example and other zero-heavy data sets analyzed in the 
literature [5, 13, 26]. Each simulation study consists of 1000 independent samples. For 
comparison, we also considered a limited number of simulation scenario for 20% and 60% 
zeroes. These results presented in the web appendix.  
3.2 Simulation results 
In Table 1, we recorded the percent relative mean bias and the asymptotic standard errors for the 
marginal beta coefficients after fitting MTP-GG, MTP-gamma, MTP-Weibull, MTP-lognormal 
and MTP log skew normal.  
For small sample size (N=100) the percent relative mean bias for the intercept was extremely 
high for MTP-lognormal when the data set was simulated from MTP-gamma with shape 
parameter 0.2 (-137.75%) or from MTP-Weibull with shape parameter 0.25 (-111.59%). Also, 
the asymptotic standard errors were in general larger for MTP-lognormal compared to the other 
models. The percent relative mean bias for the intercept was moderate for MTP-Weibull (-
8.14%) when the data set was simulated from MTP-gamma with shape 0.25, and similarly for the 
MTP-gamma (9.27%) when the data were simulated from MTP-Weibull with shape 0.25, 
whereas the bias for MTP-GG was lower (2.06%, 3.99%). The MTP-gamma (6.36%, 5.33%) led 
to slightly biased estimates for the treatment effect when the data set was MTP-Weibull with 
shape 0.25 or MTP-lognormal with variance 4, respectively. In terms of percent relative mean 
bias for the treatment effect, MTP-Weibull (0.69%, 2.97%) performed better than MTP-gamma 
(3.71%, 5.33%) or MTP-GG (5.41%, 3.64%) when the data set was simulated from MTP-gamma 
shape 0.2 or MTP-lognormal with variance 4. MTP-GG (0.62%, 0.59%) performed better than 
MTP lognormal (0.73%, 1.82%), MTP-gamma (0.76%, 6.36%) or MTP-Weibull (0.99%, 1.52%) 
when the data set was simulated from MTP-gamma shape 10 or MTP-Weibull shape 0.25, 
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respectively. When data were simulated from an MTP-GG model, the MTP-GG resulted in 
slightly lower relative percent bias comparative to MTP-Weibull and MTP-gamma for all model 
parameters but MTP lognormal had the lowest bias in the treatment effect (0.22%). Of note, the 
distribution of the parameter estimates from the 1000 simulated samples was not always 
symmetric or normally distributed and therefore we also recorded the median relative percent 
bias and median standard error which are also presented in the Web Table 1. However, results 
based on the median were very similar with the results based on the mean relative percent bias.  
For large sample size (N=1000) the intercept was highly biased for both MTP-lognormal (-
148.97, -22.17%) and MTP log skew normal (-119.93%, -44.06%) when the data set was 
simulated from MTP-gamma with shape parameter 0.2 or from MTP-Weibull with shape 
parameter 0.25. Moreover, the MTP-lognormal and MTP log skew normal had the largest 
asymptotic standard errors when the data set was simulated from MTP-gamma or MTP-Weibull. 
The percent relative mean bias in the intercept was moderately upwards for MTP-Weibull (-
10.18%)  when the data set was simulated from MTP-gamma with shape parameter 0.2, whereas 
the bias was slightly upwards for the treatment effect for MTP-gamma (2.10%) when the data set 
was simulated from MTP-Weibull with shape 0.25. In general, MTP-GG had lower bias for the 
treatment effect comparative to other models form the GG family. Moreover, MTP-GG (0.24%, 
0.21%, 0.33%, -0.03%) had the lowest bias for the treatment effect among all models when the 
data set was simulated from MTP-Weibull with shape 0.25, MTP lognormal with variance 2 or 4 
or MTP-GG. The results based on the median percent relative bias were similar with the 
exception the MTP log skew normal which showed less bias in the intercept (Web Table 1).  
The convergence rates for all models are presented in Web Table 4. The MTP log skew normal 
(as low as 17%) and MTP-GG (as low as 55%) had low rates of convergence when sample size 
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was small. For large sample size, the MTP-GG rates of convergence were low (65.3%) when the 
data set was simulated from MTP-lognormal variance 2 and 4, respectively. For all other 
scenarios, the convergence was 100%. MTP log skew normal had lower rates of convergence 
(between 81% and 93%) for large sample size when the data set was simulated from MTP-
gamma or MTP-Weibull any shape. For small samples, it is expected that more complex models 
such as MT-GG and MTP log skew normal to have lower convergence rates. However, for larger 
samples, non-convergence may be viewed as a computational issue. For large samples, MTP-GG 
had lower rates of convergence only when the true model was MTP-lognormal. The lognormal 
distribution is a limiting distribution of GG, as the shape parameter of the GG goes to zero, 
which may cause the model not to converge. Based on these results, the non-convergence of GG 
for large sample sizes could be used to select a simpler model such as MTP-lognormal. 
Moreover, in a real data set different initial values can be used for the model parameters until the 
model reaches convergence.  
In Table 2 we present the 95% coverage for 2  corresponding to the treatment effect for 
different simulation scenarios. For small as well as for large sample sizes, MTP-gamma had the 
lowest coverage (N=100: as low as 70.8%, N=1000: as low as 58.6%) when the data set was 
simulated from MTP-Weibull with shape 0.25 or MTP lognormal variance 2 or 4. The departures 
from the nominal coverage level for MTP-gamma were more severe with increased sample size. 
MTP-Weibull had slightly lower than nominal coverage (~87%), for large and small sample size, 
when the data set was simulated from MTP-lognormal with variance 2 or 4. MTP-GG had 
coverage that is slightly closer to the nominal 95% for all scenarios with slightly lower coverage 
(N=100: 89.7%, N=1000: 91.8%) when the data set was simulated from MTP-gamma shape 
0.25. When the data set was simulated from MTP-gamma shape 2 and 10, or from MTP-Weibull 
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shape 2 or 10 the coverage of MTP-GG (93.4%, 94%, 95.9%, 94.3%) was slightly better than 
MTP-Weibull (92.7%, 91.3%, 94.1%, 91.4). MTP-lognormal had good coverage for all scenarios 
but also increased standard errors comparative to other models.  
In Figure 1 we compared type 1 error rates. MTP-gamma had type 1 error rates that were higher 
than normal (N=100: as high as .292, N=1000: as high as .450) when the data set was simulated 
from MTP-lognormal with variance  2 or 4, or MTP-Weibull with shape 0.25.Type one error 
rates for MTP-gamma increased with large sample size. MTP-Weibull had relatively high type 
one error rates (N=100: as high as .122, N=1000: as high as .133) when the data set was 
simulated from MTP-lognormal variance 2 or 4, and the results did not improve with larger 
sample size. However, MTP-Weibull had nominal levels for type one error rate for all other 
simulation scenarios. All other MTP models had type one error rates around the 0.05 nominal 
level. 
Power is presented in Figure 2. We compared the power levels only for scenarios where the type 
one error rate did not exceed nominal levels since the power may seem higher as a consequence 
of increased type one error rate. MTP-lognormal followed by MTP log skew normal had lowest 
power in detecting a treatment effect when the data set was simulated from MTP-gamma shape 
0.2 and shape 2 or MTP-Weibull shape 0.25 or 2.  . As expected, the power was higher for all 
models as the sample increased. When the data set was simulated from MTP-Weibull or from 
MTP-gamma shape 2 or shape 10, MTP-Weibull followed by MTP-GG had best power.   
For each simulation scenario, we also recorded the average and median estimates for the shape 
and scale parameter after fitting MTP-GG for the 1000 simulated samples. The results are 
presented in Web Table 6. When the data set was simulate from MTP-gamma the shape and 
scale parameters of MTP-GG were very close. When the data set was simulated from MTP-
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Weibull, the shape parameter of MTP-GG was close to one. When the data set was simulated 
from MTP-lognormal the shape parameter of the MTP-GG was close to zero. All these suggest 
that the parameter estimates of MTP-GG could be used as an additional tool when selecting the 
best model fit.  This can be useful especially for small sample size when the choice of the model 
is more important to get unbiased inference. In order to determine the best model, we also looked 
at the percent of times the model was selected based on the smallest AIC. For small sample sizes, 
AIC did not discriminate well between the models when the data set was simulated from MTP-
gamma or MTP-Weibull. AIC was more efficient to identify the true model when the data set 
was simulated from MTP-lognormal (~78% of the time). As the sample size increased, AIC 
performed better and the right model was identified 78% of the times or more for all simulation 
scenarios. We present AIC results in Web Table 5.  
Results for 20% and 60% zeroes are presented in Web Table 7, for data simulated from MTP-
GG (0.3, 5) for a sample size of 1000. The results are similar to the simulation results based on 
40% zeroes, suggesting that MTP-GG is a good alternative for any scenario. For 20% zeroes, the 
measures of performance improve for all models with the exception of type one error rates which 
are slightly increased comparative to 60% zeroes. 
To sum up, for small sample sizes it is not straightforward to choose a model that performs well 
for any distribution of the data. If the sample is small and the interest is focused on estimating 
the treatment effect, the MTP lognormal, in general, leads to smaller bias, reduced type one error 
rate and good 95% coverage comparative to the other models.  However, for larger sample sizes, 
our simulations show that the bias for the treatment effect is small and the power is optimal for 
the more complex models such as MTP-GG and MTP log skew normal. If the interest is 
prediction, the investigator should be careful when using an MTP lognormal or MTP log skew 
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normal which lead to highly biased intercepts when the true model is MTP-gamma or MTP-
Weibull with small shape parameters.  In addition, the MTP-gamma and MTP-Weibull lead to 
increased type one error rates, regardless of sample size, when the true model is MTP lognormal. 
However, in general MTP Weibull performs better than MTP gamma. Therefore, we conclude 
that MTP-GG is a good alternative for analysis of semi-continuous data when sample size is 
large whereas MTP-LN is a good starting point when sample size is small. The estimated shape 
and scale parameters of MTP-GG can be used to identify a better model.  
4.  Data Example 
4.1 Description of the data  
The first data set is derived from a study that investigated the relative effectiveness of  
motivational interviewing (GMI), compared to a treatment control condition (TCC) for dually 
diagnosed veterans for enhancing treatment engagement and lowering substance use in an 
outpatient substance abuse treatment program. Participants were randomized to GMI (n=59) or 
TCC (n=59). Patients attended four 75- minute sessions of GMI or TCC across four consecutive 
days. A study coordinator blind to study conditions evaluated participants at baseline and at a 1 
and 3-month follow-up. Two of the primary outcomes for the study were peak standard ethanol 
content (peakSEC) and money spent on alcohol in US dollars (ALCmoney), measured at 3 
months follow-up. Secondary measures included Treatment Motivation Questionnaire (TMQ; 
[27]), the Short Inventory of Problems (SIP-R; [28]), and post-traumatic stress disorder (PTSD). 
The primary hypotheses were based on comparing GMI to TCC at the three month follow-up 
after adjusting for any baseline differences. The aim of the study was to know the impact of GMI 
for the overall population without restricting the interpretation only for those with positive values 
of the outcomes.  
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The second data example makes use of the publically available micro-data from the consolidated 
Medical Expenditure Panel Survey (MEPS), household component 2011 (HC-147). The interest 
is to compare the adult non-Hispanic whites with one of the fastest growing minority group in 
US, which is the non-Hispanic Asian population [29]. To identify the target populations, we 
make use of the race and ethnicity variables in MEPS-HC files that are provided to facilitated 
analysis for minority groups. Our aim is to determine if there are any differences in total health 
care expenditures (TOTEXP11), and emergency room (ER) expenditures (ERTEXP11) in 2011, 
between the adult (>=18 years) US noninstitutionalized non-Hispanic white and non-Hispanic 
Asian civilians, without conditioning on observing a non-zero expense. Of note, our method does 
not currently provide a way to adjust for sampling weights and therefore our analysis will 
produce sample specific estimates. However, our purpose is to provide a data example for the 
proposed methodology and therefore the adjustment for sampling weights can be disregarded in 
the context of this article but will be considered for future work. Results are presented on the 
main dependent covariate across different MTP models.  
4.2 Results of the data analysis 
4.2.1 Case study 1 
For the randomized clinical trial example, all secondary measures TMQ, PTSD, and SIP were 
included in the continuous part of the MTP model in addition to the baseline measure specific to 
each outcome.  Only TMQ was included in the binary part. These decisions were made based on 
model fit (smallest AIC). peakSEC and alcMoney have an increased percentage of zero (40% 
and 48%) and long far right tails with different degrees of skewness, as presented in the Web 
Figure 2 in the web appendix. In Web Table 4, we recorded the AIC and the log likelihood for 
different MTP models for each outcome (MTP-GG, MTP-gamma, MTP-Weibull, MTP 
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lognormal, MTP log skew normal). In addition, we provided the shape and scale parameter 
estimated by MTP-GG model to aid in the decision of model selection, when available. For 
peakSEC the smallest AIC was for MTP-gamma followed by MTP log skew normal. However, 
the model fit were almost the same for all models with differences in AICs of one or two units. 
The shape and scale parameters from the MTP-GG model were close in value (0.71 and 0.54) 
which also suggested that true model could be MTP-gamma. Assuming MTP-gamma is the best 
model, we conclude no significant treatment effect for peakSEC at 3 months. MTP-GG led to 
similar results as MTP-gamma. For money spent on alcohol the smallest AIC was for MTP-
lognormal followed by MTP-gamma. The models are not nested so we cannot use a likelihood 
ratio test. However, the shape parameter k  estimated by MTP-GG was very small (0.08) which 
suggested that the true model could be MTP-lognormal. Assuming MTP-lognormal is the true 
model, we conclude there is no treatment effect on ALCmoney at three months follow up. We 
also note that both MTP-gamma and MTP-Weibull resulted in significant treatment effect which 
could be due to a type-I error as observed in our simulation studies. MTP-GG yield similar 
results to best model choice, MTP lognormal. 
In terms of other covariates included in the models, TMQ was negatively associated with 
peakSEC in the continuous part which suggests that higher levels of treatment motivation were 
associated with lower levels of peakSEC at 3 months follow up, PTSD was positively associated 
with peakSEC which suggests that having PTSD is associated with an increase in the amount of 
money spend on alcohol at 3 months follow-up. In addition, TMQ was significantly and 
negatively associated with the probability of having a non-negative outcome for both outcomes. 
This suggests that higher levels of motivations increase the probability of no substance use as 
well as the probability of spending no money on alcohol. More specific, the exponentiated alpha 
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coefficient corresponding to TMQ, in the MTP-lognormal model for peakSEC can be interpreted 
as a unit increase in TMQ decreases the chances of having a non-zero outcome at 3 months by a 
4% (OR=0.96; CI: 0.95 to 0.99).  Similarly, the exponentiated beta coefficients can be 
interpreted as the percent change in the marginal mean of peakSEC for one unit increase in the 
covariate. For example, the subjects in the GMI treatment group had RR=0.79 (CI: 0.54 to 1.15) 
times lower levels of peakSEC at 3 months follow up (or a reduction of 21%) compared to 
subjects in the TCC group after adjusting for baseline peakSEC levels and other covariates.  
In summary, the MTP models with the best model fit suggested a decrease in the substance use 
levels and money spent on alcohol at three months in the GMI treatment group compared to TCC 
group, but none reached statistical significance.  
4.2.2 Case study 2 
Summary statistics for the second data example from MEPS are presented in Appendix Table 1. 
The total sample size considered for analysis was 13,239, where 86.2% were whites and 13.8% 
were Asians. The mean age for this sample was 48.3 (  18.1 years) with the majority of subjects 
being insured (82.6%) and currently married (56%). The most prevalent comorbidities were 
hypertension (33.03%), joint pain (35.9%) and high cholesterol (31.75%).The outcomes 
considered for analysis, total health care cost and ER cost, had an increased percentage of zeroes, 
16% and 88%, respectively. The mean total health care cost in US dollars was 5,124.52 
(±23,472.74), whereas the mean ER cost was 178.07  931.44. In order to analyze these semi-
continuous outcomes and obtain coefficients with marginal interpretation (i.e. unconditional on 
observing a positive value), we use the proposed MTP models. Based on clinician suggestion and 
on the literature [30], the same set of covariates is included in both parts of the model.  In 
addition to the main dependent covariate race (Asian, white), the analysis is adjusted for 
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important confounders, such as age, gender, marital status, education, income as percent of 
poverty line, insured, region, depression, cardio vascular disease, (any of myocardial infraction, 
angina, coronary heart disease, and other heart disease), and comorbidities such as hypertension, 
joint pain, stroke, emphysema, high cholesterol, arthritis, asthma, and diabetes (see Table 1). For 
total health care expenditures, the smallest AIC corresponds to MTP log skew normal 
(AIC=189,771), closely followed by MTP-GG (AIC=189,779). The parameter estimates and 
standard errors are shown in Table 1. Based MTP-log skew normal model, we conclude that 
there is a significant difference in total health care cost in 2011 between the non-Hispanic whites 
and non-Hispanic Asians living in US. The rate ratio of total health care cost for Asians versus 
total health care cost for whites was RR=exp( -0.53)=0.59 (95% CI: 0.54, 0.65) which suggests 
that on average, the total health care cost in 2011 for the non-Hispanic Asian population was 
41% less than the total cost for the non-Hispanic white population. Of note, other models such 
MTP gamma (exp(-0.32)=0.73) and MTP Weibull (exp(-0.39)=.68) yield lower magnitude of 
associations between race and total health care expenditures.  For the second outcome, total ER 
expenditures, the best model fit corresponds to MTP-GG (AIC=25,254), followed by MTP-log 
skew normal (AIC=25,276) with a difference in AICs of 22 units. The MTP-GG shape and scale 
parameters ( 0.62,  1.11k    ) do not match any subfamily of the GG distribution which also 
confirms that a more comprehensive model such as MTP-GG is a better model fit. Base on MTP-
GG, we conclude that there is a significant difference in total ER expenditures for 2011 between 
whites and Asians living in US. More specific, the total ER cost for 2011 was 60% (RR=0.40, 
95%CI: (0.28, 0.57)) lower for non-Hispanic Asians comparative to non-Hispanic whites living 
in US. For the total ER expenditures outcome, all models yield similar parameter estimation and 
statistical significance of the race covariate. In addition to the marginal coefficients in the 
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continuous part, the investigator has the information on the alpha coefficients from the binary 
part of the MTP model which are also presented in Table1. Based on the models with the 
smallest AIC, the log odds of having health care expenditures (alpha=-0.73; 95% CI: 1.00, -0.57) 
as well as the log odds of having ER expenditures (alpha=-0.75; 95%CI: -0.99, -0.51) in 2011 
were significantly lower for non-Hispanic Asians comparative to non-Hispanic whites.  
5. Conclusions and future work 
In this paper we developed marginalized two-part models for the generalized gamma family of 
distributions (gamma and Weibull distributions).  Other distributions such as lognormal, inverse 
gamma, exponential, chi-square, half normal, Rayleigh, and Maxwell-Boltzmann distribution 
[18, 31] can also be derived as special cases of the GG.  
When the sample is small, a simpler model, such as the MTP lognormal may be sufficient to 
obtain optimal estimation of marginal treatment effect. We also showed that for multiple 
simulation scenarios MTP-Weibull performed better than MTP-gamma and therefore MTP-
Weibull is another good alternative for a real data application with small sample size. These 
findings are also consistent with other studies available in the literature [21]. 
Our simulation results as well as the data example, also demonstrate that when the sample is 
large enough, a more complex model, such as MTP-GG, will lead to more accurate and reliable 
results. Based on our simulations, MTP-GG is superior to all other models when data is truly 
MTP-GG. Moreover, MTP-GG performs better than the other models for multiple other 
scenarios such as when the true data is MTP-Weibull or MTP lognormal. Therefore, MTP-GG is 
a good alternative for marginal estimation of treatment effect and marginal predictions, 
regardless of the true underlying distribution of the data, and especially when the sample size is 
large. These results are consistent with findings from other articles [5].  One challenge with 
24 
 
MTP-GG was convergence which is expected for data with small sample sizes since this is a 
more complex model.  However, for larger sample sizes, non-convergence of MTP-GG, may 
suggest that the best fitting model is most likely MTP lognormal and therefore MTP lognormal 
can be used as an alternative.  In a real data application, we can also improve convergence of the 
more complex models, by using different initial values especially for the shape and scale 
parameter which was an efficient way for reaching convergence in our real data example. The 
grid search in PROC NLMIXED could also be used to select the optimal combination of initial 
values for all model parameters.  
Given that continuous outcomes with a point mass at zero are frequent in biomedical research, 
the proposed models are very useful for researchers that are interested in marginal inference for 
the whole population while accounting for the large proportion of zeroes. We showed that the 
MTP models for the GG family of distributions can accommodate a variety of data scenarios. 
The choice of the distribution depends on factors such as sample size, with larger sample size 
favoring a more complex model such as MTP GG, and a smaller sample size favoring simpler 
models such as MTP lognormal or MTP Weibull. Moreover, our simulation results as well as the 
real data applications, demonstrate that the shape/scale parameter estimates of the GG 
distribution can help select the best fitting model similar to what we can get from using the AIC.  
For future work, it would be useful to develop a formal test based on MTP-GG parameters to 
decide if a simpler distribution from the GG family is more appropriate.  Also, the proposed 
models could be further extended to longitudinal/ clustered data and their performance when 
missigness is present also needs to be investigated.  
Supplementary Materials 
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Web appendices, tables, and figures referenced in the simulation and results sections, as well as 
SAS code implementing the MTP-GG, MTP-gamma, and MTP-Weibull, are available with this 
paper at the Statistics in Medicine website on Wiley Online Library.  
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Appendix 
SAS code for MTP GG: 
%macro mtp_gg(data,outcome); 
proc nlmixed data=&data maxiter=500; 
parms  a0=0.1 a1=0.1 a2=0.1 b0=0.1 b1=0.1 b2=0.1 sigma=1  t=1; 
 teta=a0+a1*x1+a2*x2; 
 expteta=exp(teta); 
 p=expteta/(1+expteta); 
 if &outcome=0 then loglik=log(1-p); 
 if &outcome>0 then do; 
  mu=b0 + b1 * x1 + b2 * x2 -log(p) - log(t**(-2*sigma*t)) - 
log(gamma(t*t+sigma*t)/gamma(t*t)); 
  eta=abs(t)**(2); 
  u=sign(t)*(log(&outcome)-mu)/sigma; 
  value1=(eta-.5)*log(eta) - log(sigma)-log(&outcome)-lgamma(eta); 
  loglik=log(p)+value1 + u*sqrt(eta)-eta*exp(1/(abs(t))*u); 
 end; 
  model &outcome ~general(loglik); 
  ods output "Parameter Estimates"=est_gg "Convergence Status"=conv_gg "Fit 
Statistics"=fit_gg; 
run; 
%mend mtp_gg; 
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SAS code for MTP Gamma (special case of GG): 
%macro mtp_g(data,outcome); 
proc nlmixed data=&data maxiter=500; 
parms  a0=0.1 a1=0.1 a2=0.1 b0=0.1 b1=0.1 b2=0.1 t=1; 
 teta=a0+a1*x1+a2*x2; 
 expteta=exp(teta); 
 p=expteta/(1+expteta); 
 if &outcome=0 then loglik=log(1-p); 
 if &outcome>0 then do; 
  mu=b0 + b1 * x1 + b2 * x2 -log(p) ; 
  eta=abs(t)**(2); 
  u=sign(t)*(log(&outcome)-mu)*t; 
  value1=(eta-.5)*log(eta) + log(t)-log(&outcome)-lgamma(eta); 
  loglik=log(p)+value1 + u*sqrt(eta)-eta*exp(1/(abs(t))*u); 
 end; 
  model &outcome ~general(loglik); 
  ods output "Parameter Estimates"=est_g "Convergence Status"=conv_g "Fit 
Statistics"=fit_g; 
run; 
%mend mtp_g; 
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SAS code for MTP Weibull (special case of GG): 
%macro mtp_w(data,outcome); 
proc nlmixed data=&data maxiter=500; 
parms  a0=0.1 a1=0.1 a2=0.1 b0=0.1 b1=0.1 b2=0.1 sigma=1 ; 
 teta=a0+a1*x1+a2*x2; 
 expteta=exp(teta); 
 p=expteta/(1+expteta); 
 if &outcome=0 then loglik=log(1-p); 
 if &outcome>0 then do; 
  mu=b0 + b1 * x1 + b2 * x2 -log(p) - log(gamma(1+sigma)); 
  eta=abs(1)**(2); 
  u=sign(1)*(log(&outcome)-mu)/sigma; 
  value1=(eta-.5)*log(eta) - log(sigma)-log(&outcome)-lgamma(eta); 
  loglik=log(p)+value1 + u*sqrt(eta)-eta*exp(1/(abs(1))*u); 
 end; 
  model &outcome ~general(loglik); 
  ods output "Parameter Estimates"=est_w "Convergence Status"=conv_w "Fit 
Statistics"=fit_w; 
run; 
%mend mtp_w; 
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Table 1. Simulation results: estimates of bias and standard errors for MTP parameters  
  LN G W GG LSN 
Sim. 
From 
Coef. %rel. 
bias 
ASE %rel. 
bias 
ASE %rel. 
bias 
ASE %rel. 
bias 
ASE %rel. 
bias 
ASE 
N=100 
G 
s=0.2 
β0 
β1 
β2 
-137.75 
-0.90 
1.05 
4.1909 
0.354 
1.3438 
2.31 
-0.78 
3.71 
1.7619 
0.1806 
0.6402 
-8.14 
-0.69 
2.50 
2.4012 
0.2419 
0.9037 
2.06 
-1.53 
5.41 
1.8797 
0.1957 
0.6518 
-1.26 
5.73 
-4.82 
2.2159 
0.226 
0.8009 
G 
s=2 
β0 
β1 
β2 
-0.32 
-0.22 
0.70 
0.6584 
0.0686 
0.2659 
0.47 
0.38 
0.93 
0.6066 
0.0637 
0.247 
0.42 
-0.38 
1.08 
0.5876 
0.0619 
0.2388 
0.57 
-0.77 
1.03 
0.979 
0.1026 
0.2846 
0.76 
-1.22 
0.78 
0.6106 
0.0644 
0.2475 
G 
s=10 
β0 
β1 
β2 
0.07 
0.05 
0.73 
0.351 
0.0388 
0.1613 
0.24 
-0.26 
0.76 
0.3458 
0.0383 
0.1598 
0.53 
-0.93 
0.99 
0.3354 
0.0373 
0.1561 
0.35 
-0.50 
0.62 
0.3487 
0.0386 
0.1615 
0.31 
-0.44 
0.54 
0.3456 
0.0384 
0.1596 
W 
s=0.25 
β0 
β1 
β2 
-111.59 
-1.90 
1.82 
4.2618 
0.361 
1.3679 
9.27 
1.53 
6.36 
2.2797 
0.2352 
0.7794 
3.71 
-0.03 
1.52 
2.8852 
0.2911 
1.0807 
3.99 
-0.15 
0.59 
2.9255 
0.2879 
1.0625 
-0.51 
0.64 
-0.26 
3.1502 
0.304 
1.1165 
W 
s=2 
β0 
β1 
β2 
-0.47 
0.31 
0.41 
0.5622 
0.0594 
0.2317 
0.26 
-0.12 
0.41 
0.5191 
0.0552 
0.2169 
0.34 
-0.33 
0.57 
0.4811 
0.0515 
0.2033 
0.37 
-0.53 
0.60 
0.479 
0.0513 
0.2023 
0.39 
-0.41 
0.72 
0.5026 
0.0544 
0.2062 
W 
s=10 
β0 
β1 
β2 
-0.08 
0.29 
0.41 
0.175 
0.0223 
0.0933 
-0.01 
0.15 
0.45 
0.1724 
0.0221 
0.0923 
1.90 
-3.63 
-0.55 
0.1533 
0.0199 
0.0828 
1.89 
-3.70 
-0.43 
0.1544 
0.0201 
0.0831 
0.66 
-1.21 
0.004 
0.1664 
0.0214 
0.0899 
LN 
σ2=2 
β0 
β1 
β2 
0.33 
1.51 
0.40 
1.0618 
0.1077 
0.41 
0.78 
2.13 
3.04 
0.9919 
0.1027 
0.3763 
1.48 
1.81 
2.34 
1.0454 
0.1079 
0.4016 
1.58 
0.97 
1.71 
1.0626 
0.108 
0.4114 
-0.47 
1.61 
0.53 
1.0742 
0.1071 
0.4079 
LN 
σ2=4 
β0 
β1 
β2 
1.07 
1.77 
0.33 
1.4753 
0.1465 
0.5556 
3.98 
2.63 
5.33 
1.3266 
0.137 
0.4848 
6.16 
2.12 
2.97 
1.4292 
0.1465 
0.5432 
4.39 
1.83 
3.64 
1.545 
0.1511 
0.5757 
0.45 
2.24 
0.39 
1.5089 
0.1462 
0.5543 
GG 
s=0.5 
k=3 
β0 
β1 
β2 
-1.91 
0.51 
0.22 
0.9507 
0.0969 
0.3708 
-0.13 
1.51 
1.53 
0.8302 
0.0862 
0.3251 
-0.07 
1.45 
1.45 
0.8481 
0.0879 
0.3322 
0.32 
0.34 
0.91 
0.8904 
0.0918 
0.3506 
-0.07 
-0.06 
0.83 
0.9038 
0.0933 
0.3502 
N=1000 
G 
s=0.2 
β0 
β1 
β2 
-148.97 
0.57 
0.86 
1.3527 
0.1131 
0.4346 
0.31 
-0.32 
0.71 
0.5051 
0.0515 
0.1967 
-10.18 
-0.26 
0.82 
0.7419 
0.07448 
0.286 
0.32 
-0.33 
0.65 
0.5004 
0.0509 
0.1948 
-22.71 
1.25 
0.19 
0.644 
0.0618 
0.2363 
G 
s=2 
β0 
β1 
β2 
-0.87 
0.17 
0.19 
0.2071 
0.0215 
0.0841 
-0.08 
0.22 
0.16 
0.1878 
0.0197 
0.0775 
-0.13 
0.23 
0.18 
0.1815 
0.0191 
0.0752 
-0.08 
0.24 
0.15 
0.1877 
0.0197 
0.0774 
-0.63 
0.21 
0.09 
0.2011 
0.0209 
0.0821 
G 
s=10 
β0 
β1 
β2 
-0.14 
0.28 
0.15 
0.108 
0.0119 
0.0500 
-0.09 
0.25 
0.17 
0.1061 
0.0118 
0.0494 
-0.02 
0.13 
0.19 
0.1024 
0.0114 
0.0481 
-0.09 
0.24 
0.16 
0.1061 
0.0118 
0.0494 
-0.13 
0.29 
0.09 
0.108 
0.0119 
0.0500 
W 
s=0.25 
β0 
β1 
β2 
-119.93 
-0.97 
-0.26 
1.3555 
0.1135 
0.4354 
0.74 
2.38 
2.10 
0.6237 
0.0637 
0.2344 
0.35 
0.14 
0.36 
0.8892 
0.0892 
0.3415 
0.44 
0.08 
0.24 
0.9019 
0.0892 
0.3412 
-44.06 
-0.34 
0.59 
1.0789 
0.0985 
0.377 
W β0 -0.51 0.1752 0.08 0.1599 0.06 0.1471 0.07 0.147 -0.19 0.1636 
34 
 
s=2 β1 
β2 
-0.13 
0.03 
0.0184 
0.0728 
-0.14 
0.07 
0.0169 
0.0676 
-0.11 
0.13 
0.0157 
0.0632 
-0.12 
0.12 
0.0157 
0.0631 
-0.19 
0.09 
0.0173 
0.0688 
W 
s=10 
β0 
β1 
β2 
0.01 
-0.02 
0.06 
0.0529 
0.0067 
0.0283 
0.02 
-0.04 
0.07 
0.0519 
0.0066 
0.0279 
0.05 
-0.11 
0.12 
0.0440 
0.0059 
0.0240 
0.05 
-0.12 
0.12 
0.044 
0.0059 
0.0239 
0.03 
-0.05 
0.05 
0.0519 
0.0066 
0.0278 
LN 
σ2=2 
β0 
β1 
β2 
 0.04 
0.21 
0.35 
0.3334 
0.0337 
0.1301 
-0.06 
0.90 
0.35 
0.3022 
0.0311 
0.1191 
1.00 
0.62 
0.35 
0.328 
0.0337 
0.1295 
0.61 
0.51 
0.21 
0.3481 
0.0347 
0.1331 
-0.25 
0.25 
0.39 
0.3365 
0.0337 
0.1301 
LN 
σ2=4 
β0 
β1 
β2 
0.14 
0.24 
0.40 
0.4644 
0.0458 
0.1766 
0.58 
1.67 
0.43 
0.3993 
0.0409 
0.154 
4.89 
0.83 
0.39 
0.4496 
0.0458 
0.1758 
1.95 
0.43 
0.33 
0.4949 
0.0489 
0.1854 
-0.67 
0.06 
0.34 
0.4798 
0.0459 
0.1766 
GG 
s=0.5 
k=3 
β0 
β1 
β2 
-2.10 
-0.42 
-0.10 
0.2999 
0.0305 
0.1179 
0.18 
-0.43 
0.33 
0.2555 
0.0264 
0.1021 
0.33 
-0.42 
0.07 
0.2639 
0.0272 
0.1053 
0.28 
-0.45 
-0.03 
0.2766 
0.0284 
0.1101 
-1.16 
-0.60 
-0.12 
0.2916 
0.0298 
0.1151 
ASE=Asymptotic Standard Error; GG=generalized gamma, G=gamma, W=Weibull, LN=Log-Normal, LSN=Log-Skew-Normal; 
in the first column, for each MTP gamma and Weibull simulation scenario the true shape parameter is provided whereas for the 
lognormal distribution the true sigma value is provided; the parametrization of Weibull and gamma for the simulated data is 
consistent with the parametrizations described in the method section; all simulated and fitted models are MTP models: the beta 
coefficients represent the marginal coefficients corresponding to the continuous part of MTP model and more specific, the % 
relative mean bias for each beta was computed as 100*(true – mean)/abs(true). A negative value of the relative percent bias 
suggests the parameter is overestimated and a negative value suggests it is underestimated.  
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Table 2. Simulation Results: 95% CI coverage probability estimates (true 2 1.5    ) 
Sim.from N=100 N=1000 
MTP LN G W GG LSN LN G W GG LSN 
G (s=0.2) 93.6 93.0 97.4 89.7 97.7 94.7 92.3 96.9 91.8 92.5 
G (s=2) 95.6 93.9 92.7 93.0 92.9 93.9 94.7 94.3 94.9 94.1 
G (s=10) 94.0 94.0 91.3 93.4 93.4 95.0 95.6 93.3 95.4 95.2 
W (s=0.25) 94.8 72.8 95.0 93.6 93.4 95.2 55.0 96.4 95.8 96.0 
W (s=2) 94.3 95.9 94.1 94.1 93.5 94.7 96.0 95.4 95.6 94.3 
W (s=10) 93.8 94.3 91.4 90.4 90.3 94.6 95.2 94.5 94.3 94.9 
LN (σ2=2) 95.7 81.5 88.6 95.2 94.0 95.4 76.3 87.2 94.3 95.4 
LN (σ2=4) 95.7 70.8 87.8 94.9 94.5 95.1 58.6 86.7 94.8 94.9 
GG(s=0.5, k=3) 94.8 92.1 92.4 93.7 93.2 93.0 90.4 92.4 94.1 93.3 
MTP=Marginalized two part model, GG=generalized gamma, G=gamma, W=Weibull, LN=Log-Normal, LSN=Log-Skew-
Normal; s is the shape parameter and sigma is the true standard deviation on the log scale; 
The true parameters of the simulated MTP models are 
' (4.9, 0.4, 1)     and ' (6.3, 0.3, 1.5)     
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Table 3. Model coefficient estimates, standard errors and statistical significance at alpha=0.05 
level for the substance use data across different MTP models 
Outcome Coefficients MTP LN MTP G MTP W MTP GG MTP LSN 
Peak  
SEC 
Alphas 
   Int 
   TMQ 
Betas 
   Int 
   GMI 
   Bline 
   PTSD 
   SIP 
   TMQ  
 
4.94(1.556) 
-0.03(.012)* 
 
3.66(.633) 
-0.29(.207) 
0.01(.009) 
0.44(.218)* 
0.02(.011) 
-0.02(.006)* 
 
5.50(1.625) 
-0.04(.012)* 
 
3.25(.655) 
-0.24(.191) 
0.02(.009) 
0.36(.200) 
0.01(.010) 
-0.02(.006)* 
 
5.60(1.636) 
-0.04(.012)* 
 
3.15(.677) 
-0.18(.185) 
0.02(.010)* 
0.33(.195) 
0.009(.010) 
-0.02(.006)* 
 
4.21(.013) 
-0.03(.002)* 
 
3.31(.674) 
-0.26(.201) 
0.02(.010) 
0.37(.209) 
0.01(.011) 
-0.02(.006)* 
 
5.51(1.663) 
-0.04(.012)* 
 
3.34(.672) 
-0.24(.208) 
0.02(.009) 
0.38(.205) 
0.01(.011) 
-0.02(.006)* 
Alcohol 
Money 
Alphas 
   Int 
   TMQ 
Betas 
   Int 
   GMI 
   Bline 
   PTSD 
   SIP 
   TMQ  
 
4.58(1.489) 
-0.03(.011)* 
 
3.79(1.065) 
-0.41(.365) 
0.006(.002)* 
0.19(.367) 
0.004(.020) 
-0.006(.010) 
 
4.55(1.479) 
-0.03(.011)* 
 
2.09(1.034) 
-0.85(.338)* 
0.009(.002)* 
-0.10(.405) 
-0.01(.227) 
0.01(.009) 
 
4.56(1.490) 
-0.03(.011)* 
 
2.36(1.097) 
-0.80(.360)* 
0.009(.002)* 
-0.02(.421) 
-0.009(.023) 
0.008(.010) 
 
4.65(.896) 
-0.04(.007)* 
 
3.71(.675) 
-0.44(.352) 
0.007(.002)* 
0.19(.344) 
0.003(.020) 
-0.006(.006) 
 
NC 
NC 
 
NC 
NC 
NC 
NC 
NC 
NC 
*significant at alpha level 0.05;  
MTP=marginalized two part model; GG=generalized gamma, G=gamma, W=Weibull, LN=Log-Normal, LSN=Log-Skew-
Normal; 
NC=Non-Convergent; GMI= group motivational interview; SEC= standard ethanol content; PTSD=Post Traumatic Syndrome 
Disorder; SIP=Short Inventory of Problems; TMQ=Treatment Motivation Questionnaire;  
For all outcomes, the covariates included in the continuous part of the model are the baseline measure, PTSD, SIP and TMQ; the 
binary part includes only the TMQ covariate; 
Note that for more complex models such as MTP GG and MTP LSN it may be necessary to try different initial staring values 
especially for the shape/scale parameters in order to get convergence; 
Best model for PEAKSEC is MTP gamma; Best model for alcohol money is MTP LN;  
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Table 4. Model coefficient estimates, standard errors and statistical significance at alpha=0.05 level for 
MEPS data across different MTP models  
Outcome Coeff. MTP LN MTP G MTP W MTP GG MTP LSN 
Total  
health 
exp. 
Alphas 
  Int 
  Asian 
Betas 
  Int 
  Asian 
 
1.34(0.201) 
-0.73(0.077)* 
 
6.71(0.100) 
-0.54(0.050)* 
 
1.18(0.201) 
-0.98(0.074)* 
 
7.20(0.088) 
-0.32(0.048)* 
 
1.29(0.202) 
-0.80(0.078)* 
 
6.99(0.098) 
-0.39(0.050)* 
 
1.39(0.200) 
-0.72(0.077)* 
 
6.70(0.099) 
-0.53(0.050)* 
 
1.37(0.201) 
-0.73(0.077)* 
 
6.69(0.099) 
-0.53(0.050)* 
Total  
ER  
exp. 
Alphas 
  Int 
  Asian 
Betas 
  Int 
  Asian 
 
-1.78(0.190) 
-0.75(0.122)* 
 
5.44(0.264) 
-0.93(0.182)* 
 
-1.79(0.189) 
-0.74(0.122)* 
 
5.49(0.246) 
-0.89(0.169)* 
 
-1.79(0.190) 
-0.75(0.122)* 
 
5.48(0.256) 
-0.90(0.175)* 
 
-1.79(0.190) 
-0.75(0.122)* 
 
5.43(0.260) 
-0.92(0.180)* 
 
-1.78(0.190) 
-0.75(0.122)* 
 
5.44(0.264) 
-0.94(0.182)* 
*significant at alpha 0.05 level;  
MTP=marginalized two part model; GG=generalized gamma, G=gamma, W=Weibull, LN=Log-Normal, LSN=Log-Skew-
Normal; 
For these analyses, the same set of covariates were included in both part of the MTP model based on clinicians suggestion: age 
(continuous), gender (male ,female), marital status (married, not married), education (less than high school, high school, college, 
graduate), income as percent of poverty line (below or near poverty line, low, middle and high income), insured (yes, no), region 
(Northeast, Midwest, South, West), depression (yes, no), cardio vascular disease (yes, no) (any of myocardial infraction, angina, 
coronary heart disease, and other heart disease), and comorbidities such as hypertension (yes, no), joint pain (yes, no), stroke 
(yes, no), emphysema (yes, no), high cholesterol (yes, no), arthritis (yes, no), asthma (yes, no) and diabetes (yes, no). 
Best model for Total health care expenditures is MTP LSN; Best model for total ER expenditures is MTP GG;  
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